Navigation Links
Pacific Fertility Center Physicians Interviewed by the Media about New Fertility Benefits Offered by Facebook and Apple
Date:10/16/2014

San Francisco, CA (PRWEB) October 16, 2014

Childbearing and career may be mutually exclusive for some women. But two tech giants are now addressing that conundrum by offering unprecedented egg-freezing fertility benefits. Covering this news, local and national media sought the expertise of Pacific Fertility Center (PFC) physicians on the technical aspects of this development.

Facebook began offering egg freezing and storage as part of its benefits package earlier this year; Apple will begin in January of 2015. Each egg-freezing procedure usually costs about $10,000, and annual storage costs are around $500. Although each company offers slightly different policies, both cover up to $20,000 for egg freezing, a procedure not typically covered by insurance for non-medical reasons.

No longer considered experimental by the American Society for Reproductive Medicine (ASRM), fertility preservation allows women to capture and store a number of good quality eggs, preventing the otherwise inevitable deterioration, and allowing them to be thawed and fertilized when it’s more convenient to create a family.

PFC President Carl M. Herbert, MD, told ABC7 and CBS-SF Bay Area he’s seen an increase in requests for the technology in recent years, which may benefit those who need years to develop a top-level career. He explained that the best time to freeze eggs is in a woman’s early 30s when the numbers of eggs are more plentiful and quality higher. The viability and quality of unfrozen eggs residual in the ovaries will reduce over time.

Philip E. Chenette, MD, called the benefit “payback” for women’s commitment to the workplace and told NBC News that egg freezing has empowered women to pursue both career and childrearing in a timeframe that works better for them.
Although this new benefit may help attract and keep women in high-tech, both Facebook and Apple will also cover up to $20,000 in benefits to cover sperm donation and infertility benefits to men as well.

About Pacific Fertility Center
Pacific Fertility Center is an international destination for male and female fertility treatment and care. It provides an extensive array of fertility treatment options ranging from intrauterine insemination (IUI), intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF) to cutting-edge technology such as vitrification and genetic testing of embryos. For more information: http://www.pacificfertilitycenter.com.

###

Media Contact
Renee H. Scudder, MS
415-249-3662
scudder(at)pacificfertility(dot)com

Pacific Fertility Center
55 Francisco Street, Fifth Floor
San Francisco, CA 94133

Read the full story at http://www.prweb.com/releases/2014/10/prweb12255699.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Nihon Kohden Dominating High-Tech Asia-Pacific Patient Monitoring Market, Chased by Philips Healthcare, GE Healthcare, and Fukuda Denshi
2. Innovations TV Program to Feature Pacific Medical in 1Q 2015 series on Medical Breakthroughs.
3. Pulse Oximeter Market Expected to Grow to over $1.3 Billion by 2020 in the U.S., Asia Pacific, and Europe Combined
4. Pacific Prime Announced as Finalist for the Asia Insurance Industry Awards
5. Asia-Pacific Glioblastoma Multiforme (GBM) Market Size Industry Analysis, Share, Growth, Trends and Forecast to 2020: MarketResearchReports.biz
6. Asia-Pacific Water Soluble Fertilizers Market is Expected to Reach $2,482.3 Million in 2018 - New Report by MicroMarket Monitor
7. Asia-Pacific Multi-Function Display Market is Expected to Reach $4066.20 Million in 2020 - New Report by MicroMarket Monitor
8. Asia-Pacific Phytochemicals & Plant Extracts (Nutraceuticals) Market is Expected to Reach $1,463.6 million in 2018 - New Report by MicroMarket Monitor
9. Asia-Pacific Baking Enzymes Market is Expected to Reach $147.8 Million in 2018 - New Report by MicroMarket Monitor
10. Global Market for Biopsy Devices to Reach $1.9 Billion by 2018; Asia-Pacific Market Holds the Largest Share
11. Asia-Pacific Market for Infusion Therapy Devices Led by Terumo, JMS and Nipro Medical is expected to reach over $900 million by 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa ... contributed a medical article to the newly revamped Cosmetic Town journal ... the hair transplant procedure known as Follicular Unit Extraction (FUE). , ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
(Date:9/22/2017)... , Sept. 22, 2017  As the latest ... Senators Bill Cassidy (R-LA) and Lindsey ... notes that the medical device industry is in an ... device tax, the 2.3% excise tax on medical device ... they also want covered patients, increased visits and hospital ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: